A global research team co-led by VCU expert Kenneth Kendler has produced the most comprehensive genetic map so far, identifying five families of disorders that show a high degree of overlap. An intern ...

The drug, CUTX-101, is intended for the treatment of Menkes disease, a rare X-linked recessive genetic disorder affecting ...

Fortress and its majority-owned subsidiary, Cyprium Therapeutics, said the FDA has accepted an NDA resubmission for CUTX-101, or copper histidinate, a treatment for children who suffer from Menkes ...

Researchers have demonstrated in the WISDOM trial that integrating criteria-independent genetic testing into routine breast ...

If approved, CUTX-101 will be the first and only FDA-approved treatment available for Menkes disease, a rare X-linked ...

Sentynl Therapeutics, Inc. ("Sentynl"), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. ("Zydus Group"), today announced that the U.S. Food and Drug Administration (FDA ...

The CUTX-101 NDA was initially granted Priority Review by the FDA and is supported by positive topline clinical efficacy ...

A new study has provided new insights into the the genetic overlap among some psychiatric disorders, and can help explain why it's not uncommon... | Genetics And Genomics ...

This large-scale genomic analysis of 14 psychiatric disorders shows that most heritable risk is shared across five broad ...

This important study establishes the first vertebrate models of DeSanto-Shinawi Syndrome, revealing conserved craniofacial and social and behavioral phenotypes across mouse and zebrafish that mirror ...

Researchers from around the world have found new clues about why many people have more than one psychiatric disorder at the same time. In a large study, published in Nature ...

Cross-species functional genomics identify ribosomal protein genes as key regulators of cardiomyocyte proliferation and heart development, implicating them as candidate modifiers for HLHS and ...